ZNF496 as Candidate Gene for Neurodevelopmental Disorders: Identification of a Pathogenic De Novo Frameshift Variant
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26157586 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Francesco Calì und 9 weiteren Autor:innen. Beteiligte Einrichtung: Oasi Research Institute-IRCCS, 94018 Troina, Italy. Hauptthemen laut MEDLINE: Frameshift Mutation, Genetic Predisposition to Disease, Neurodevelopmental Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health “Ricerca Corrente 2017–2023”, 5xmille.
Abstract (Originalsprache)
Zinc finger proteins are frequently implicated in a wide range of neurodevelopmental disorders (NDDs). In this study, we report a case of mild intellectual disability (ID), global developmental delay (GDD), and developmental coordination disorder (DCD) in an individual with unaffected parents. Trio-based whole-exome sequencing (WES) identified a de novo variant (c.1530dup, p.Glu511ArgfsTer16) in the ZNF496 gene of the proband. According to ACMG guidelines, this novel variant is classified as pathogenic. It creates a frameshift that introduces a premature stop codon, resulting in a truncated protein of 525 amino acids (compared to the wild-type 587 residues). Notably, NMDEscPredictor analysis predicted that the transcript escapes nonsense-mediated decay (NMD) despite the frameshift. Computational analyses suggest the potential pathogenetic effects of the identified variant. As documented, ZNF496 interacts with JARID2, a gene associated with NDDs, ID and facial dysmorphism (MIM: #620098). In silico analyses suggest that the identified mutation disrupts this interaction by deleting ZNF496’s C2H2 domain, potentially dysregulating JARID2 target genes. To our knowledge, this is the first reported association between ZNF496 and NDDs, and the variant has been submitted to the ClinVar database (SCV006100880). Functional studies are imperative to validate ZNF496’s role in NDDs and confirm the mutation’s impact on ZNF496-JARID2 interactions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Oasi Research Institute-IRCCS, 94018 Troina, Italy.
- Department Biological, Geological and Environmental Sciences, University of Catania, Via Androne 81, 95124 Catania, Italy.
ORCID-Profile: Francesco Calì, Miriam Virgillito, Simone Treccarichi, Antonino Musumeci, Carla Papa, Rosanna Galati Rando, Salvatore Saccone, Mirella Vinci
Förderung
- Italian Ministry of Health “Ricerca Corrente 2017–2023”
- 5xmille
Zitieren
APA
Calì, F., Virgillito, M., Treccarichi, S., Musumeci, A., Failla, P., Papa, C., Galati Rando, R., Federico, C., Saccone, S., & Vinci, M. (2025). ZNF496 as Candidate Gene for Neurodevelopmental Disorders: Identification of a Pathogenic De Novo Frameshift Variant. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26157586
Vancouver
Calì F, Virgillito M, Treccarichi S, Musumeci A, Failla P, Papa C, et al. ZNF496 as Candidate Gene for Neurodevelopmental Disorders: Identification of a Pathogenic De Novo Frameshift Variant. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26157586
BibTeX
@article{Cal2025,
author = {Calì, Francesco and Virgillito, Miriam and Treccarichi, Simone and Musumeci, Antonino and Failla, Pinella and Papa, Carla and Galati Rando, Rosanna and Federico, Concetta and Saccone, Salvatore and Vinci, Mirella},
title = {ZNF496 as Candidate Gene for Neurodevelopmental Disorders: Identification of a Pathogenic De Novo Frameshift Variant},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26157586}
}
EUVIMED